1 Min Read
Feb 21 (Reuters) - Lupin Ltd:
* GETS U.S. FDA APPROVAL FOR GENERIC TAMIFLU FOR ORAL SUSPENSION Source text - bit.ly/2sPD9z5 Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.